Matt Liu

614 total citations
5 papers, 153 citations indexed

About

Matt Liu is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Matt Liu has authored 5 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Epidemiology and 2 papers in Immunology. Recurrent topics in Matt Liu's work include Urinary Tract Infections Management (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Respiratory viral infections research (1 paper). Matt Liu is often cited by papers focused on Urinary Tract Infections Management (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Respiratory viral infections research (1 paper). Matt Liu collaborates with scholars based in United States and France. Matt Liu's co-authors include Robin Buckland, J Fayolle, Merete Blixenkrone-Møller, Thorsten Wild, Alicia I. Cardoso, Andrew Murphy, Gábor Halász, Jie Dai, Douglas MacDonald and Joel Martin and has published in prestigious journals such as Cancer Research, Virology and Toxicological Sciences.

In The Last Decade

Matt Liu

5 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matt Liu United States 4 70 53 37 32 27 5 153
Cheryl Selinsky United States 6 74 1.1× 74 1.4× 60 1.6× 40 1.3× 25 0.9× 9 177
Josephine F. Reijneveld United States 10 158 2.3× 49 0.9× 65 1.8× 67 2.1× 47 1.7× 14 272
Victor I. Ayala United States 7 103 1.5× 36 0.7× 82 2.2× 22 0.7× 36 1.3× 9 206
On Ho United States 8 103 1.5× 37 0.7× 22 0.6× 90 2.8× 43 1.6× 23 238
David S. Quinn United States 4 124 1.8× 68 1.3× 54 1.5× 133 4.2× 41 1.5× 8 268
Fahmida Hoq United States 8 75 1.1× 139 2.6× 48 1.3× 49 1.5× 59 2.2× 16 231
Jennifer Hutchinson United States 5 88 1.3× 56 1.1× 59 1.6× 35 1.1× 12 0.4× 7 203
Dimana Dimitrova United States 8 62 0.9× 13 0.2× 30 0.8× 19 0.6× 35 1.3× 26 135
Elizabeth M. Parzych United States 8 89 1.3× 29 0.5× 81 2.2× 55 1.7× 31 1.1× 13 181
Marc C. Shamier Netherlands 6 48 0.7× 40 0.8× 114 3.1× 122 3.8× 22 0.8× 10 237

Countries citing papers authored by Matt Liu

Since Specialization
Citations

This map shows the geographic impact of Matt Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Liu more than expected).

Fields of papers citing papers by Matt Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Liu. The network helps show where Matt Liu may publish in the future.

Co-authorship network of co-authors of Matt Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Matt Liu. A scholar is included among the top collaborators of Matt Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt Liu. Matt Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Wang, Hui, Christian Atsriku, Andrew T. Placzek, et al.. (2025). Abstract 4376: Preclinical characterization of SGR-4174, a potent and selective SOS1 inhibitor for the treatment of pan KRAS mutant cancers in combination with KRAS pathway inhibitors. Cancer Research. 85(8_Supplement_1). 4376–4376. 1 indexed citations
2.
Anjos, Carolina dos, Yin Wang, Q. C. Truong-Bolduc, et al.. (2024). Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance. Lasers in Surgery and Medicine. 56(7). 673–681. 5 indexed citations
3.
Bannister, Roy, et al.. (2021). COVID-19 Therapeutics and Vaccines: A Race to Save Lives. Toxicological Sciences. 185(2). 119–127. 10 indexed citations
4.
Burova, Elena, Aynur Hermann, Jie Dai, et al.. (2019). Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3 –Knockin Mice. Molecular Cancer Therapeutics. 18(11). 2051–2062. 62 indexed citations
5.
Cardoso, Alicia I., Merete Blixenkrone-Møller, J Fayolle, et al.. (1996). Immunization with Plasmid DNA Encoding for the Measles Virus Hemagglutinin and Nucleoprotein Leads to Humoral and Cell-Mediated Immunity. Virology. 225(2). 293–299. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026